Develops software for pharmaceutical companies to switch prescription drugs to over-the-counter medications.
Dec 2024Revenue $5.11M/yrExpenses $9.74M/yr
No trendCash runway ≈ 11 months from Jun 2026
Figures by year
When will Petros Pharmaceuticals be profitable?
Its figures don’t show a steady enough trend to project a date. In the 12 months to Dec 2024, revenue was $5.11M and expenses $9.74M.
| Fiscal year to | Revenue | Expenses | Operating profit |
|---|---|---|---|
| Dec 2024 | $5.11M | $9.74M | −$4.63M |
| Dec 2023 | $5.82M | $19.4M | −$13.6M |
| Dec 2022 | $5.99M | $25.9M | −$19.9M |
| Dec 2021 | $7.81M | $25.9M | −$18.0M |
| Dec 2020 | $9.56M | $26.8M | −$17.3M |
When the cash runs out, on the chart. A red line at the date the company’s cash would run out at its latest burn, so you can see whether it gets to break-even first. Part of a subscription.